Company intelligence / Profile preview

Improvement at Work

Ownership: Private
Development stage: Commercial

Overview

Improvement at Work is a specialized consulting firm that partners with biotech and pharmaceutical companies to accelerate and optimize their first regulatory submissions—such as NDA or MAA—to agencies like the FDA or EMA. The company leverages its proprietary Excellenza methodology to provide tailored support in regulatory strategy, project management, submission planning, resource optimization, and embedded coaching. It is particularly focused on helping early-stage companies prepare for successful interactions with regulators and achieve organizational readiness for major submissions[1].

Modalities: Small molecule
Industry: Consulting

Beyond the preview

Go deeper on Improvement at Work.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Improvement at Work.

Explore the full profile